In the absence of the low density lipoprotein receptor, human apolipoprotein C1 overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway - PubMed (original) (raw)
In the absence of the low density lipoprotein receptor, human apolipoprotein C1 overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway
M C Jong et al. J Clin Invest. 1996.
Abstract
To study the role of apoC1 in lipoprotein metabolism, we have generated transgenic mice expressing the human APOC1 gene. On a sucrose-rich diet, male transgenic mice with high APOC1 expression in the liver showed elevated levels of serum cholesterol and triglyceride compared with control mice (5.7+/-0.7 and 3.3+/-2.1 vs. 2.7+/-0.1 and 0.4+/-0.1 mmol/liter, respectively). These elevated levels were mainly confined to the VLDL fraction. Female APOC1 transgenic mice showed less pronounced elevated serum lipid levels. In vivo VLDL turnover studies revealed that, in hyperlipidemic APOC1 transgenic mice, VLDL particles are cleared less efficiently from the circulation as compared with control mice. No differences were observed in the hepatic production and extrahepatic lipolysis of VLDL-triglyceride. Also, VLDL isolated from control and APOC1 transgenic mice were found to be equally good substrates for bovine lipoprotein lipase in vitro. These data indicate that the hyperlipidemia in APOC1 transgenic mice results primarily from impaired hepatic VLDL particle clearance, rather than a defect in the hydrolysis of VLDL-triglyceride. To investigate which hepatic receptor is involved in the apoC1-mediated inhibition of VLDL clearance, APOC1 transgenic mice were bred with an LDL receptor-deficient (LDLR(-/-)) background. In addition, control, LDLR(-/-), and LDLR(-/-)/APOC1 mice were transfected with adenovirus carrying the gene for the receptor-associated protein (Ad-RAP). Both serum cholesterol and triglyceride levels were strongly elevated in LDLR(-/-)/APOC1 mice compared with LDLR(-/-) mice (52+/-19 and 36+/-19 vs. 8.4+/-0.9 and 0.5+/-0.2 mmol/liter, respectively), indicating that apoC1 inhibits the alternative VLDL clearance pathway via the remnant receptor. Transfection of LDLR(-/-) mice with Ad-RAP strongly increased serum cholesterol and triglyceride levels, but to a lesser extent than those found in LDLR(-/-)/APOC1 mice (39+/-8 and 17+/-8 vs. 52+/-19 and 36+/-19 mmol/liter, respectively). However, in LDLR(-/-)/APOC1 mice the transfection with Ad-RAP did not further increase serum cholesterol and triglyceride levels (52+/-19 and 36+/-19 vs. 60+/-10 and 38+/-7 mmol/liter, respectively). From these studies we conclude that, in the absence of the LDLR, apoC1 inhibits the hepatic uptake of VLDL via a RAP-sensitive pathway.
Similar articles
- Reversal of hyperlipidaemia in apolipoprotein C1 transgenic mice by adenovirus-mediated gene delivery of the low-density-lipoprotein receptor, but not by the very-low-density-lipoprotein receptor.
Jong MC, van Dijk KW, Dahlmans VE, Van der Boom H, Kobayashi K, Oka K, Siest G, Chan L, Hofker MH, Havekes LM. Jong MC, et al. Biochem J. 1999 Mar 1;338 ( Pt 2)(Pt 2):281-7. Biochem J. 1999. PMID: 10024503 Free PMC article. - Modulation of very low density lipoprotein production and clearance contributes to age- and gender- dependent hyperlipoproteinemia in apolipoprotein E3-Leiden transgenic mice.
van Vlijmen BJ, van 't Hof HB, Mol MJ, van der Boom H, van der Zee A, Frants RR, Hofker MH, Havekes LM. van Vlijmen BJ, et al. J Clin Invest. 1996 Mar 1;97(5):1184-92. doi: 10.1172/JCI118532. J Clin Invest. 1996. PMID: 8636429 Free PMC article. - Both lipolysis and hepatic uptake of VLDL are impaired in transgenic mice coexpressing human apolipoprotein E*3Leiden and human apolipoprotein C1.
Jong MC, Dahlmans VE, van Gorp PJ, Breuer ML, Mol MJ, van der Zee A, Frants RR, Hofker MH, Havekes LM. Jong MC, et al. Arterioscler Thromb Vasc Biol. 1996 Aug;16(8):934-40. doi: 10.1161/01.atv.16.8.934. Arterioscler Thromb Vasc Biol. 1996. PMID: 8696956 - Insights into apolipoprotein C metabolism from transgenic and gene-targeted mice.
Jong MC, Havekes LM. Jong MC, et al. Int J Tissue React. 2000;22(2-3):59-66. Int J Tissue React. 2000. PMID: 10937355 Review.
Cited by
- Circadian Regulation of Apolipoproteins in the Brain: Implications in Lipid Metabolism and Disease.
Lee CH, Murrell CE, Chu A, Pan X. Lee CH, et al. Int J Mol Sci. 2023 Dec 12;24(24):17415. doi: 10.3390/ijms242417415. Int J Mol Sci. 2023. PMID: 38139244 Free PMC article. Review. - APOC1 promotes the progression of osteosarcoma by binding to MTCH2.
Li R, He H, He X. Li R, et al. Exp Ther Med. 2023 Feb 23;25(4):163. doi: 10.3892/etm.2023.11862. eCollection 2023 Apr. Exp Ther Med. 2023. PMID: 36911382 Free PMC article. - Role of apolipoprotein C1 in lipoprotein metabolism, atherosclerosis and diabetes: a systematic review.
Rouland A, Masson D, Lagrost L, Vergès B, Gautier T, Bouillet B. Rouland A, et al. Cardiovasc Diabetol. 2022 Dec 5;21(1):272. doi: 10.1186/s12933-022-01703-5. Cardiovasc Diabetol. 2022. PMID: 36471375 Free PMC article. Review. - Association of lipid metabolism-related gene promoter methylation with risk of coronary artery disease.
Li W, Wang Y, Huang R, Lian F, Xu G, Wang W, Xue S. Li W, et al. Mol Biol Rep. 2022 Oct;49(10):9373-9378. doi: 10.1007/s11033-022-07789-0. Epub 2022 Aug 8. Mol Biol Rep. 2022. PMID: 35941416 - Apolipoprotein C1 promotes glioblastoma tumorigenesis by reducing KEAP1/NRF2 and CBS-regulated ferroptosis.
Zheng XJ, Chen WL, Yi J, Li W, Liu JY, Fu WQ, Ren LW, Li S, Ge BB, Yang YH, Zhang YZ, Yang H, Du GH, Wang Y, Wang JH. Zheng XJ, et al. Acta Pharmacol Sin. 2022 Nov;43(11):2977-2992. doi: 10.1038/s41401-022-00917-3. Epub 2022 May 17. Acta Pharmacol Sin. 2022. PMID: 35581292 Free PMC article.
References
- J Clin Invest. 1994 May;93(5):2215-23 - PubMed
- J Clin Invest. 1994 Apr;93(4):1683-90 - PubMed
- Atherosclerosis. 1994 Nov;111(1):25-37 - PubMed
- Biochem J. 1995 Feb 1;305 ( Pt 3):905-11 - PubMed
- Proc Natl Acad Sci U S A. 1995 May 9;92(10):4537-41 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Miscellaneous